Kazunori Otomo1, Taro Horino2, Takeo Miki1, Hiromi Kataoka3, Yutaka Hatakeyama3, Tatsuki Matsumoto4, Kazu Hamada-Ode4, Yoshiko Shimamura4, Koji Ogata4, Kosuke Inoue4, Yoshinori Taniguchi4, Yoshio Terada4, Yoshiyasu Okuhara3. 1. Center for Innovative and Translational Medicine, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Japan. 2. Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan. horinott@yahoo.co.jp. 3. Center of Medical Information Science, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Japan. 4. Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Abstract
BACKGROUND AND OBJECTIVES: Recent studies have shown that both low and high levels of serum uric acid (SUA) before cardiovascular surgery are independent risk factors for postoperative acute kidney injury (AKI). However, these studies were limited by their small sample sizes. Here, we investigated the association between SUA levels and AKI by performing a retrospective database analysis of almost 30 years of data from 81,770 hospitalized patients. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENT: Hospitalized patients aged ≥18 years were retrospectively enrolled. AKI was diagnosed according to the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline (KDIGO) criteria. Multivariate logistic regression analyses were performed to investigate the independent association between SUA levels and the incidence of AKI. SUA levels were treated as categorical variables because the relationship between SUA and the incidence of AKI has been suggested to be J-shaped or U-shaped. In addition to stratified SUA levels, we considered kidney function and related comorbidities, medications, and procedures performed prior to AKI onset as possible confounding risk factors. RESULTS: The final study cohort included 59,219 adult patients. Adjusted odds ratios of AKI incidence were higher in both the high- and low-SUA strata. Odds ratios tended to become larger in the higher range of SUA levels in women than in men. Additionally, this study showed that AKI risk was elevated in patients with SUA levels ≤7 mg/dL. An SUA level >7 mg/dL is considered the point of initiation of uric acid crystallization. CONCLUSIONS: SUA level could be an independent risk factor for AKI development in hospitalized patients. Additionally, our results might suggest that intervention to lower SUA levels is necessary, even in cases of moderate elevation that does not warrant hyperuricemia treatment. Results also showed that SUA levels that require attention are lower for women than for men.
BACKGROUND AND OBJECTIVES: Recent studies have shown that both low and high levels of serum uric acid (SUA) before cardiovascular surgery are independent risk factors for postoperative acute kidney injury (AKI). However, these studies were limited by their small sample sizes. Here, we investigated the association between SUA levels and AKI by performing a retrospective database analysis of almost 30 years of data from 81,770 hospitalized patients. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENT: Hospitalized patients aged ≥18 years were retrospectively enrolled. AKI was diagnosed according to the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline (KDIGO) criteria. Multivariate logistic regression analyses were performed to investigate the independent association between SUA levels and the incidence of AKI. SUA levels were treated as categorical variables because the relationship between SUA and the incidence of AKI has been suggested to be J-shaped or U-shaped. In addition to stratified SUA levels, we considered kidney function and related comorbidities, medications, and procedures performed prior to AKI onset as possible confounding risk factors. RESULTS: The final study cohort included 59,219 adult patients. Adjusted odds ratios of AKI incidence were higher in both the high- and low-SUA strata. Odds ratios tended to become larger in the higher range of SUA levels in women than in men. Additionally, this study showed that AKI risk was elevated in patients with SUA levels ≤7 mg/dL. An SUA level >7 mg/dL is considered the point of initiation of uric acid crystallization. CONCLUSIONS:SUA level could be an independent risk factor for AKI development in hospitalized patients. Additionally, our results might suggest that intervention to lower SUA levels is necessary, even in cases of moderate elevation that does not warrant hyperuricemia treatment. Results also showed that SUA levels that require attention are lower for women than for men.
Entities:
Keywords:
AKI; Acute kidney injury; Hyperuricemia; Hypouricemia; Medical database analysis
Authors: Michael E Matheny; Randolph A Miller; T Alp Ikizler; Lemuel R Waitman; Joshua C Denny; Jonathan S Schildcrout; Robert S Dittus; Josh F Peterson Journal: Med Decis Making Date: 2010-03-30 Impact factor: 2.583
Authors: Annika Ahlström; Minna Tallgren; Seija Peltonen; Pirjo Räsänen; Ville Pettilä Journal: Intensive Care Med Date: 2005-07-28 Impact factor: 17.440
Authors: A Ahsan Ejaz; Wei Mu; Duk-Hee Kang; Carlos Roncal; Yuri Y Sautin; George Henderson; Isabelle Tabah-Fisch; Birgit Keller; Thomas M Beaver; Takahiko Nakagawa; Richard J Johnson Journal: Clin J Am Soc Nephrol Date: 2006-12-06 Impact factor: 8.237
Authors: Melanie Kolz; Toby Johnson; Serena Sanna; Alexander Teumer; Veronique Vitart; Markus Perola; Massimo Mangino; Eva Albrecht; Chris Wallace; Martin Farrall; Asa Johansson; Dale R Nyholt; Yurii Aulchenko; Jacques S Beckmann; Sven Bergmann; Murielle Bochud; Morris Brown; Harry Campbell; John Connell; Anna Dominiczak; Georg Homuth; Claudia Lamina; Mark I McCarthy; Thomas Meitinger; Vincent Mooser; Patricia Munroe; Matthias Nauck; John Peden; Holger Prokisch; Perttu Salo; Veikko Salomaa; Nilesh J Samani; David Schlessinger; Manuela Uda; Uwe Völker; Gérard Waeber; Dawn Waterworth; Rui Wang-Sattler; Alan F Wright; Jerzy Adamski; John B Whitfield; Ulf Gyllensten; James F Wilson; Igor Rudan; Peter Pramstaller; Hugh Watkins; Angela Doering; H-Erich Wichmann; Tim D Spector; Leena Peltonen; Henry Völzke; Ramaiah Nagaraja; Peter Vollenweider; Mark Caulfield; Thomas Illig; Christian Gieger Journal: PLoS Genet Date: 2009-06-05 Impact factor: 5.917
Authors: Hans U Gerth; Michele Pohlen; Dennis Görlich; Gerold Thölking; Martin Kropff; Wolfgang E Berdel; Hermann Pavenstädt; Marcus Brand; Philipp Kümpers Journal: PLoS One Date: 2016-05-06 Impact factor: 3.240
Authors: Anand Srivastava; Ragnar Palsson; David E Leaf; Angelica Higuera; Margaret E Chen; Polly Palacios; Rebecca M Baron; Venkata Sabbisetti; Andrew N Hoofnagle; Sucheta M Vaingankar; Paul M Palevsky; Sushrut S Waikar Journal: Kidney Med Date: 2019-01-15